skip to content

Kirkstall wins TSB backing for Regenerative Medicine Project

Kirkstall will collaborate with RegenTec and partners in Sheffield and Nottingham Universities to deliver improved tissue growth and monitoring technology. The investment in the project is part of the Technology Strategy Board managed £21.5 million Regenerative Medicine Programme.

RegenMed results 5dec11 final

"The Kirkstall advanced cell culture system is a very important new tool for the research community offering a highly attractive combination of better quality data and lower costs."

Prof. Patrick Maurel, Research Director at INSERM, University of Montpellier.